The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Ciltacabtagene autoleucel, a BCMA-targeting CAR T-cell therapy, significantly slows or stops progression of multiple myeloma…
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric…
Results from the largest prospective study of primary mediastinal B-cell lymphoma show that radiation therapy…
While the incidence of colorectal cancer (CRC) has dropped significantly among older adults in recent…
In a phase 2 clinical trial of the immune checkpoint inhibitor pembrolizumab, investigators found that…
Over the past decade, the approval of immune checkpoint inhibitors has revolutionised treatment for patients…
Adding the targeted therapy drug ribociclib to hormonal (endocrine) therapy showed a significant improvement in…
A new clinical trial is testing the effectiveness of chemotherapy treatment following surgery for a…
The University of Alicante Applied Biochemistry research group—in collaboration with researchers from the Alicante University Hospital Dr.…
A major impediment to treating the deadly brain cancer glioblastoma has been that the most…